正在处理

请稍候...

Join our LinkedIn PATENTSCOPE users Community Group
设置

设置

查看申请

专利局 all 语言 词根提取 false 单一族成员 true 包括NPL false
只有拥有WIPO帐户才能生成RSS源

保存查询

私人查询仅在您登录后对您可见,而不能在RSS 订阅中使用

查询树

优化选项

专利局
全部
指明检索关键词的语言
词根提取功能可将屈折词还原回词根形式。
例如,fishingfishedfishfisher 这些词都会还原回词根 fish
因此检索 fisher 即可获得各种变形的所有结果
仅返回专利族的一个成员
在结果中包括非专利文献

完整查询

IC_EX:G16H* AND EN_ALLTXT:(coronavirus OR coronaviruses OR coronaviridae OR coronavirinae OR orthocoronavirus OR orthocoronaviruses OR orthocoronaviridae OR orthocoronavirinae OR betacoronavirus OR betacoronaviruses OR betacoronaviridae OR betacoronavirinae OR sarbecovirus OR sarbecoviruses OR sarbecoviridae OR sarbecovirinae OR "severe acute respiratory syndrome" OR sars OR "2019 ncov" OR covid)

并排视图快捷键

一般快捷键
转到检索输入栏
CTRL + SHIFT +
转到结果(选定结果)
CTRL + SHIFT +
转到详细信息(选定标签)
CTRL + SHIFT +
转到下一页
CTRL +
转到上一页
CTRL +
结果(首先,执行“转到结果”)
转到下一个结果/图像
/
转到上一个结果/图像
/
向上滚动
Page Up
向下滚动
Page Down
滚动至顶部
CTRL + Home
滚动至底部
CTRL + End
详细信息(首先,执行“转到详细信息”)
转到下一个标签
转到上一个标签

分析

1.WO/2021/237292METHODS OF ASSESSING RISK OF DEVELOPING A SEVERE RESPONSE TO CORONAVIRUS INFECTION
WO 02.12.2021
国际分类 C12Q 1/6883
C化学;冶金
12生物化学;啤酒;烈性酒;果汁酒;醋;微生物学;酶学;突变或遗传工程
Q包含酶、核酸或微生物的测定或检验方法;其所用的组合物或试纸;这种组合物的制备方法;在微生物学方法或酶学方法中的条件反应控制
1包含酶、核酸或微生物的测定或检验方法;其组合物;这种组合物的制备方法
68包括核酸
6876用于核酸分析的核酸产品,如引物或探针
6883用于由遗传物质改变而引起的疾病
申请号 PCT/AU2021/050507 申请人 GENETIC TECHNOLOGIES LIMITED 发明人 DITE, Gillian Sue
The present disclosure relates to methods and systems for assessing the risk of a human subject developing a severe response to a Coronavirus infection, such as a severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) virus infection.
2.WO/2021/247682METHODS FOR MITIGATING OR DIMINISHING SPREAD OF PATHOGENIC INFECTIONS
WO 09.12.2021
国际分类 G16H 50/80
G物理
16特别适用于特定应用领域的信息通信技术
H医疗保健信息学,即专门用于处置或处理医疗或健康数据的信息和通信技术
50专门适用于医疗诊断,医学模拟或医疗数据挖掘的ICT;专门适用于检测、监测或建模流行病或传染病
80用于检测、监测或模拟流行病或传染病,例如 流感
申请号 PCT/US2021/035421 申请人 ROSS, Peter M. 发明人 ROSS, Peter M.
The present methods comprise initial administration of a first rapid test, such as rapid antigen test, that has a low likelihood of false positive results and a known likelihood of false negative results, alone or in conjunction with other rapid tests, to identify a first subpopulation of positives, to which an infection mitigation protocol (such as quarantine or the administration of a therapeutic treatment) is administered. Negatives are recorded and provisionally released from further study. A diagnostic test is then administered to this subpopulation, to identify the portion of this first subpopulation that were false positives in the first test. Ideally, a positive result for the diagnostic test is pathognomonic for the infection. Any infection mitigation protocol (such as quarantine) may then be discontinued for those testing negative in the first population and intensified for those testing positive, such as with contact tracing or other protocols, to identify all true positives and those they may have infected within the population.
3.WO/2022/056373METHODS AND RELATED ASPECTS FOR PATHOGEN DETECTION
WO 17.03.2022
国际分类 C12Q 1/34
C化学;冶金
12生物化学;啤酒;烈性酒;果汁酒;醋;微生物学;酶学;突变或遗传工程
Q包含酶、核酸或微生物的测定或检验方法;其所用的组合物或试纸;这种组合物的制备方法;在微生物学方法或酶学方法中的条件反应控制
1包含酶、核酸或微生物的测定或检验方法;其组合物;这种组合物的制备方法
34包括水解酶
申请号 PCT/US2021/050056 申请人 THE JOHNS HOPKINS UNIVERSITY 发明人 ARROYO, Netzahualcoyoti
Provided herein are methods of detecting pathogen antibodies, such as a severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), in samples. Related devices, kits, reaction mixtures, and systems are also provided.
4.20220170118METHODS AND SYSTEMS FOR DETERMINING VIRUSES IN BIOLOGICAL SAMPLES USING A SINGLE ROUND BASED POOLING
US 02.06.2022
国际分类 C12Q 1/70
C化学;冶金
12生物化学;啤酒;烈性酒;果汁酒;醋;微生物学;酶学;突变或遗传工程
Q包含酶、核酸或微生物的测定或检验方法;其所用的组合物或试纸;这种组合物的制备方法;在微生物学方法或酶学方法中的条件反应控制
1包含酶、核酸或微生物的测定或检验方法;其组合物;这种组合物的制备方法
70包括病毒或噬菌体
申请号 17535998 申请人 Indian Institute of Technology Bombay 发明人 Manoj Gopalkrishnan

Methods and systems for determining viruses in biological samples using a single round based pooling. Embodiments disclosed herein relate to quantitative testing of biological samples, and more particularly to a quantitative, non-adaptive and single round pooling method for testing of viruses (for example: Coronavirus disease of 2019 (COVID-19), Severe Acute Respiratory Syndrome (SARS), or the like) in biological samples of individuals.

5.20230212699METHODS TO DETECT AND TREAT SARS-COV-2 (COVID19) INFECTION
US 06.07.2023
国际分类 C12Q 1/70
C化学;冶金
12生物化学;啤酒;烈性酒;果汁酒;醋;微生物学;酶学;突变或遗传工程
Q包含酶、核酸或微生物的测定或检验方法;其所用的组合物或试纸;这种组合物的制备方法;在微生物学方法或酶学方法中的条件反应控制
1包含酶、核酸或微生物的测定或检验方法;其组合物;这种组合物的制备方法
70包括病毒或噬菌体
申请号 18000858 申请人 DUKE UNIVERSITY 发明人 Micah MCCLAIN

Provided are methods of making a SARS-CoV-2 (COVID-19) infection classifier for a platform, and optionally a non-COVID-19 viral infection classifier, a bacterial infection classifier, a non-infectious illness classifier, and/or a healthy subjects classifier for the platform. Methods and systems for determining the presence of SARS-CoV-2 (COVID-19) infection in a subject or for determining the viral stage of infection of a SARS-CoV-2 (COVID-19) illness in a subject suffering therefrom are also provided.

6.WO/2022/060976METHODS FOR TREATING INFECTIONS
WO 24.03.2022
国际分类 C12Q 1/6827
C化学;冶金
12生物化学;啤酒;烈性酒;果汁酒;醋;微生物学;酶学;突变或遗传工程
Q包含酶、核酸或微生物的测定或检验方法;其所用的组合物或试纸;这种组合物的制备方法;在微生物学方法或酶学方法中的条件反应控制
1包含酶、核酸或微生物的测定或检验方法;其组合物;这种组合物的制备方法
68包括核酸
6813杂交分析
6827用于突变或多态性检测
申请号 PCT/US2021/050658 申请人 THE BROAD INSTITUTE, INC. 发明人 NATARAJAN, Pradeep
The invention features methods that are useful for treatment of a patient at increased risk for infection and for selecting a patient for treatment for an infection. In various embodiments, the infection is coronavirus disease 2019 (COVID-19), sepsis, or other respiratory infections.
7.20230290467METHODS FOR TREATING INFECTIONS
US 14.09.2023
国际分类 G16H 20/10
G物理
16特别适用于特定应用领域的信息通信技术
H医疗保健信息学,即专门用于处置或处理医疗或健康数据的信息和通信技术
20特别适用于治疗或健康改善计划的ICT,例如用于处理处方,用于引导治疗或监测患者对医嘱的执行
10涉及药物或药方,例如确保对患者进行正确的治疗
申请号 18121496 申请人 The Broad Institute, Inc. 发明人 Pradeep NATARAJAN

The invention features methods that are useful for treatment of a patient at increased risk for infection and for selecting a patient for treatment for an infection. In various embodiments, the infection is coronavirus disease 2019 (COVID-19), sepsis, or other respiratory infections.

8.202211004641A SYSTEM FOR DETECTING SEVERE ACUTE RESPIRATORY SYNDROME OMICRON VARIANT OF CORONAVIRUS AND METHOD THEREOF
IN 04.02.2022
国际分类 G06Q /
G物理
06计算;推算或计数
Q专门适用于行政、商业、金融、管理、监督或预测目的的数据处理系统或方法;其他类目不包含的专门适用于行政、商业、金融、管理、监督或预测目的的处理系统或方法
申请号 202211004641 申请人 MS. MANPREET KAUR AIDEN 发明人 MS. MANPREET KAUR AIDEN
The present invention discloses a system for detecting severe acute respiratory syndrome omicron variant of coronavirus and method thereof. The system includes, but not limited to, a memory unit to store input-output data values in real-time communication; a processing unit, wherein the memory unit is disposed in communication with the processor and storing processor executable instructions, the instructions comprising instructions to: read a receptacle unit having an oligonucleotide consisting of a nucleic acid with a sequence selected from the group consisting of: SEQ ID NOS: 20, 22, 11, 12, and complements thereof.
9.WO/2022/133258REAL-TIME PREDICTION OF ADVERSE OUTCOMES USING MACHINE LEARNING
WO 23.06.2022
国际分类 A61B 5/02
A人类生活必需
61医学或兽医学;卫生学
B诊断;外科;鉴定
5用于诊断目的的测量;人的辨识
02测量脉搏、心率、血压或血流;综合的脉搏/心率/血压的测定;其他不是用于测定心血管状况的,如使用本小组技术与心电图术结合的;测量血压的心导管
申请号 PCT/US2021/064106 申请人 THE JOHNS HOPKINS UNIVERSITY 发明人 SHADE, Julie, K.
Provided herein are methods of generating models for prognosing cardiovascular outcomes for monitored subjects infected with an etiologic agent (e.g., severe acute respiratory syndrome coronavirus-2 or another etiologic agent). Related methods, systems, and computer program products are also provided.
10.20210390508System For Controlling The Spread Of Infectious Diseases
US 16.12.2021
国际分类 G06Q 10/10
G物理
06计算;推算或计数
Q专门适用于行政、商业、金融、管理、监督或预测目的的数据处理系统或方法;其他类目不包含的专门适用于行政、商业、金融、管理、监督或预测目的的处理系统或方法
10行政;管理
10办公自动化,例如电子邮件或群件的计算机辅助管理;时间管理,例如日历、提醒、会议或时间核算
申请号 17345711 申请人 Bipin KOLLURI 发明人 Bipin KOLLURI

This invention relates to systems and methods for controlling the spread of microorganism infections or infectious disease. Present invention is particularly directed to providing systems and methods that allow secure distribution of self-expiring health badges to the subjects free of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Individuals desirious of reducing the risks of infection and preventing the spread of such diseases participate in the testing program whereby regular periodic screening tests are performed to indicate the infection status of each such individual. The self-expiring badge given to infection-free individuals uses a time indicator and provides a clear indication of expiration of the badge after a predetermined period of time interval. Furthermore, the individuals may be employees of a business entity and testing all employees periodically can provide an infection-free work environment.